treatment of alternating hemiplegia
All entries for: Aspartes Pharmaceuticals Inc.
July 1, 2026
Aspartes Pharmaceuticals Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
treatment of alternating hemiplegia